ABT-414: Clinical Trials

2 trials of ABT-414, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 11Completed 1

Follow ABT-414: new trials by email Literature Review of ABT-414 trials Research Report on ABT-414

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
Whole Brain Radiation, Temozolomide, ABT-414 - Malignant Glioma, Glioblastoma Multiforme
Phase 1 / Phase 2CompletedAbbVie532015-08-242020-09-03
Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
Depatuxizumab mafodotin, Temozolomide, Lomustine - Glioblastoma
Phase 2CompletedAbbVie2662015-02-172020-05-22

Conditions studied

Glioblastoma (2)  ·  Brain Neoplasms (1)  ·  Glioma (1)  ·  Lymphoma, Follicular (1)

Sponsors

AbbVie (2)

Countries

Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Ireland (1)  ·  Italy (1)  ·  Japan (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Poland (1)

Results publications

PMID 28039367, PMID 29077941, PMID 29982805, PMID 31747009, PMID 33601293, PMID 34609773

NIH funding

2014 (1)